BIOTECH FUND FLANDERS

biotech-fund-flanders-logo

The Fund was established in 1994 to provide investment support for emerging biotech companies in the region and over its first 10 years invested some 36.3 million euro in businesses that ranged from Plant Genetic Systems, Innogenetics, Devgen and, most recently, Galapagos, a new listing on the stock exchange. Biotech Fund Flanders, whose portfolio and investment policy were managed by the Governmentรขโ‚ฌ:tm:s investment agency GIMV, was due to close investment activities after 10 years and pe... rform only follow-up tasks until 2009. The Minister for the Economy, Fientje Moerman, has announced, however, that it will continue to operate until 2010. No additional money will be made available รขโ‚ฌโ€œ the Fund has some 12 million euro of its own resources from sales of previously held shares and is to recycle this and other returns. Its current portfolio includes investments valued at 19.7 million euro in six companies

#Financial #More

BIOTECH FUND FLANDERS

Founded:
1994-01-01

Status:
Active


Investments List

Date Company Article Money raised
2020-05-28 Virovet Biotech Fund Flanders investment in Series B - Virovet 6 M EUR
2012-01-20 Pronota Biotech Fund Flanders investment in Series C - Pronota 3.7 M EUR
2009-06-29 Pronota Biotech Fund Flanders investment in Series B - Pronota 7.36 M USD
2009-02-11 ActoGeniX Biotech Fund Flanders investment in Private Equity Round - ActoGeniX 13.5 M EUR
2007-07-03 Diatos Biotech Fund Flanders investment in Series D - Diatos 12.8 M USD
2007-02-08 ActoGeniX Biotech Fund Flanders investment in Venture Round - ActoGeniX 20 M EUR
2006-08-23 Ablynx Biotech Fund Flanders investment in Series C - Ablynx 50 M USD
2004-04-06 Ablynx Biotech Fund Flanders investment in Series B - Ablynx 30 M USD
1999-10-01 Devgen Biotech Fund Flanders investment in Series B - Devgen 23 M EUR

More informations about "Biotech Fund Flanders" on Search Engine